根据名称进行药物检索

Adempas 与 Hydrochlorothiazide and benazepril

Adempas 与 Hydrochlorothiazide and benazepril互相作用以及同时服用的可能性。

检测结果:

Adempas <> Hydrochlorothiazide and benazepril

现实性: 24.07.2022 评论家: 医学副博士Shkutko P.M., in

在该服务的官方手册中，已注明相关研究结果统计规定的互相作用。该互相作用或对患者健康引起不良后果，或起到良好效果。具体联合用药问题，需遵从医嘱。

用户:

虽然氢氯和那普利常常是结合在一起，它们的影响可以添加剂，降低你的血压力。你可能需要的剂量调整或特别的测试，以安全地把这两种药物。联系您的医生，如果你有一个降低心率、头晕晕倒，或头痛。重要的是要告诉你的医生关于所有其他药物的使用，包括维生素和草药。不停止使用任何药物，没有第一个说你的医生。

医界专家:

监测：虽然他们经常是结合在临床实践中，利尿剂和血管紧张素转换酶(ACE)，抑制剂可能具有附加效果。共同给予使得低血压和血容量更可能并不比任何一单独的药物. 一些ACE抑制剂可能减轻增加的尿排泄钠造成的一些环利尿剂。有些病人在利尿剂，特别是那些在透析或膳食盐的限制，可能会遇到严重低血压有头晕晕后接收的第一次剂量的王牌抑制剂。此外，ACE抑制剂可能造成肾功能不全或急性肾功能衰竭的患者钠损耗或肾动脉狭窄。

管理：监测血压力，利水、电解质和肾功能是建议在共同给予. 可能性的第一次剂量的血压的影响可能最小化通过发起治疗与小剂量的王牌抑制剂，或任何中止的利尿剂暂时或增加的盐的摄入量的大约一周之前发起一个王牌抑制剂。或者，病人可能仍留在医生监督下的至少两个小时后的第一次剂量的王牌抑制剂，或者直到血压力已经稳定。

来源

Murphy BF, Whitworth JA, Kincaid-Smith P "Renal insufficiency with combinations of angiotensin converting enzyme inhibitors and diuretics." Br Med J 288 (1984): 844-5
Good JM, Brady AJ, Noormohamed FH, Oakley CM, Cleland JG "Effect of intense angiotensin II suppression on the diuretic response to furosemide during chronic ACE inhibition." Circulation 90 (1994): 220-4
Radley AS, Fitzpatrick RW "An evaluation of the potential interaction between enalapril and amiloride." J Clin Pharm Ther 12 (1987): 319-23
Funck-Brentano C, Chatellier G, Alexandre JM "Reversible renal failure after combined treatment with enalapril and furosemide in a patient with congestive heart failure." Br Heart J 55 (1986): 596-8
Weisser K, Schloos J, Jakob S, et al "The influence of hydrochlorothiazide on the pharmacokinetics of enalapril in elderly patients." Eur J Clin Pharmacol 43 (1992): 173-7
McLay JS, McMurray JJ, Bridges AB, Fraser CG, Struthers AD "Acute effects of captopril on the renal actions of furosemide in patients with chronic heart failure." Am Heart J 126 (1993): 879-86
Motwani JG, Fenwick MK, Morton JJ, Struthers AD "Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure." Circulation 86 (1992): 439-45
Cerner Multum, Inc. "Australian Product Information." O 0
Lee HB, Blaufox MD "Renal functional response to captopril during diuretic therapy." J Nucl Med 33 (1992): 739-43
Thind GS "Renal insufficiency during angiotensin-converting enzyme inhibitor therapy in hypertensive patients with no renal artery stenosis." J Clin Hypertens 1 (1985): 337-43
Sudoh T, Fujimura A, Shiga T, et al. "Influence of lisinopril on urinary electrolytes excretion after furosemide in healthy subjects." J Clin Pharmacol 33 (1993): 640-3
"Product Information. Lexxel (enalapril-felodipine)." Astra Pharmaceuticals, Wayne, PA.
"Product Information. Vasotec (enalapril)." Merck & Co, Inc, West Point, PA.
Fujimura A, Shimokawa Y, Ebihara A "Influence of captopril on urinary excretion of furosemide in hypertensive subjects." J Clin Pharmacol 30 (1990): 538-42
Champ JD "Case report: azotemia secondary to enalapril and diuretic use and the diagnosis of renovascular hypertension." Am J Med Sci 305 (1993): 25-7
Hume AL, Murphy JL, Lauerman SE "Angiotensin-converting enzyme inhibitor-induced cough." Pharmacotherapy 9 (1989): 88-90
DeQuattro V "Comparison of benazepril and other antihypertensive agents alone and in combination with the diuretic hydrochlorothiazide." Clin Cardiol 14 (1991): iv28-32;
"Product Information. Aceon (perindopril)." Solvay Pharmaceuticals Inc, Marietta, GA.
"Product Information. Capoten (captopril)." Bristol-Myers Squibb, Princeton, NJ.
"Product Information. Zestrel (lisinopril)" Astra-Zeneca Pharmaceuticals, Wilmington, DE.
Lederle RM "Captopril and hydrochlorothiazide in the fixed combination multicenter trial." J Cardiovasc Pharmacol 7 (1985): S63-9
Burnakis TG, Mioduch HJ "Combined therapy with captopril and potassium supplementation: a potential for hyperkalemia." Arch Intern Med 144 (1984): 2371-2
Reader C, Peyregne EA, Suarez LD "Amrinone therapy in congestive cardiomyopathy." Am Heart J 105 (1983): 1045